126 related articles for article (PubMed ID: 18337522)
1. Rebuttal: Do you approve of spending $300 million on HPV vaccination? No.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Mar; 54(3):343, 345. PubMed ID: 18337522
[No Abstract] [Full Text] [Related]
2. Rebuttal: Do you approve of spending $300 million on HPV vaccination? Yes.
Steben M
Can Fam Physician; 2008 Mar; 54(3):342, 344. PubMed ID: 18337521
[No Abstract] [Full Text] [Related]
3. Do you approve of spending $300 million on HPV vaccination?: no.
Lippman A; Boscoe M; Scurfield C
Can Fam Physician; 2008 Feb; 54(2):175, 177, 179, 181. PubMed ID: 18272623
[No Abstract] [Full Text] [Related]
4. The ethics and politics of compulsory HPV vaccination.
Colgrove J
N Engl J Med; 2006 Dec; 355(23):2389-91. PubMed ID: 17151362
[No Abstract] [Full Text] [Related]
5. Compulsory HPV vaccination.
Basu S
N Engl J Med; 2007 Mar; 356(10):1074; author reply 1074-5. PubMed ID: 17347466
[No Abstract] [Full Text] [Related]
6. Examining mandatory HPV vaccination for all school-aged children.
Skov RE
Food Drug Law J; 2007; 62(4):805-29. PubMed ID: 18557231
[No Abstract] [Full Text] [Related]
7. The announcement by the GAVI Alliance Board to support human papillomavirus (HPV) vaccines in the world's poorest countries.
Vaccine; 2012 Nov; 30 Suppl 4():xii. PubMed ID: 23510773
[No Abstract] [Full Text] [Related]
8. Controlling cervical cancer.
Bonati M; Garattini S
Pharmacoeconomics; 2009; 27(2):91-3. PubMed ID: 19254043
[No Abstract] [Full Text] [Related]
9. [Papillomavirus vaccines now allowed--ethical and logistical considerations].
Höpfl R
J Dtsch Dermatol Ges; 2007 May; 5(5):349-52. PubMed ID: 17451379
[No Abstract] [Full Text] [Related]
10. The Global Alliance for Vaccines and Immunization (GAVI).
Schwalbe N
Vaccine; 2012 Nov; 30 Suppl 4():x. PubMed ID: 23510771
[No Abstract] [Full Text] [Related]
11. [HPV vaccination and screening to eliminate cervical cancer. FIGO report].
Ginekol Pol; 2008 Jun; 79(6):445-6. PubMed ID: 18652135
[No Abstract] [Full Text] [Related]
12. The new vaccine to prevent HPV.
Lajiness MJ
Urol Nurs; 2007 Apr; 27(2):153-4. PubMed ID: 17494457
[No Abstract] [Full Text] [Related]
13. Global elimination of cervical cancer is achievable-with commitment.
The Lancet Oncology
Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
[No Abstract] [Full Text] [Related]
14. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination.
Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Tay EH
Women Health; 2009 Jun; 49(4):334-51. PubMed ID: 19753508
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine: waiting for a miracle.
MacDonald N; Hébert PC
CMAJ; 2007 Aug; 177(5):433, 435. PubMed ID: 17724313
[No Abstract] [Full Text] [Related]
16. The economic impact of HPV vaccines: not just cervical cancer.
Myers ER
Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
[No Abstract] [Full Text] [Related]
17. Global human papillomavirus vaccination: can it be cost-effective?
Crosbie EJ
BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760
[No Abstract] [Full Text] [Related]
18. Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands.
Arbyn M; Simoens C; Van Damme P; Scharpantgen A; Meijer CJ; Beutels P
Gynecol Obstet Invest; 2010; 70(4):224-32. PubMed ID: 21051840
[TBL] [Abstract][Full Text] [Related]
19. Uganda launches HPV vaccination programme to fight its commonest cancer.
Gulland A
BMJ; 2012 Sep; 345():e6055. PubMed ID: 22966177
[No Abstract] [Full Text] [Related]
20. Challenges of implementing human papillomavirus (HPV) vaccination policy.
Raffle AE
BMJ; 2007 Aug; 335(7616):375-7. PubMed ID: 17717366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
